ONCODESIGN PRECISION MEDICIN (ALOPM.PA) Stock Price & Overview
EPA:ALOPM • FR001400CM63
Current stock price
The current stock price of ALOPM.PA is 0.475 EUR. Today ALOPM.PA is down by -1.45%. In the past month the price decreased by -4.81%. In the past year, price increased by 32.68%.
ALOPM.PA Key Statistics
- Market Cap
- 8.783M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.30
- Dividend Yield
- N/A
ALOPM.PA Stock Performance
ALOPM.PA Stock Chart
ALOPM.PA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to ALOPM.PA. When comparing the yearly performance of all stocks, ALOPM.PA is one of the better performing stocks in the market, outperforming 89.15% of all stocks.
ALOPM.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALOPM.PA. ALOPM.PA may be in some trouble as it scores bad on both profitability and health.
ALOPM.PA Earnings
ALOPM.PA Forecast & Estimates
9 analysts have analysed ALOPM.PA and the average price target is 2.04 EUR. This implies a price increase of 329.47% is expected in the next year compared to the current price of 0.475.
For the next year, analysts expect an EPS growth of 95% and a revenue growth 151.06% for ALOPM.PA
ALOPM.PA Groups
Sector & Classification
ALOPM.PA Financial Highlights
Over the last trailing twelve months ALOPM.PA reported a non-GAAP Earnings per Share(EPS) of -0.3. The EPS increased by 18.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.18% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALOPM.PA Ownership
ALOPM.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ARGX | ARGENX SE | 24.45 | 37.118B | ||
| 1AE | ARGENX SE | 24.67 | 37.043B | ||
| 22UA | BIONTECH SE-ADR | N/A | 19.08B | ||
| ABVX | ABIVAX SA | N/A | 8.492B | ||
| 2X1 | ABIVAX SA | N/A | 8.477B | ||
| GXE | GALAPAGOS NV | N/A | 1.877B | ||
| GLPG | GALAPAGOS NV | N/A | 1.854B | ||
| NANO | NANOBIOTIX | N/A | 1.365B | ||
| 6IV | INVENTIVA SA | N/A | 1.087B | ||
| IVA | INVENTIVA SA | N/A | 1.059B | ||
| PHIL | PHILOGEN SPA | 18.41 | 663.748M | ||
| XUP | GENFIT | 917.65 | 468.027M | ||
| GNFT | GENFIT | 889.71 | 440.026M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About ALOPM.PA
Company Profile
Oncodesign Precision Medicine (OPM) SAS manufactures precision medicine. The company is headquartered in Dijon, Bourgogne-Franche-Comte and currently employs 13 full-time employees. The company went IPO on 2022-10-05. The company aims at providing effective diagnostic and therapeutic solutions for resistant and metastatic cancers. The Company’s technologies from Oncodesign, are OncoSNIPER for the selection of therapeutic targets using artificial intelligence; Nanocyclix for the design and selection of macrocyclic small molecule kinase inhibitors and Theranostics for the design and selection of radiolabeled biological molecules for systemic radiotherapy. The company focuses on the research and development of therapeutic and diagnostic solutions in the clinical and preclinical areas of medical oncology.
Company Info
IPO: 2022-10-05
ONCODESIGN PRECISION MEDICIN
18 Rue Jean Mazen
Dijon BOURGOGNE-FRANCHE-COMTE FR
Employees: 14
ONCODESIGN PRECISION MEDICIN / ALOPM.PA FAQ
What does ONCODESIGN PRECISION MEDICIN do?
Oncodesign Precision Medicine (OPM) SAS manufactures precision medicine. The company is headquartered in Dijon, Bourgogne-Franche-Comte and currently employs 13 full-time employees. The company went IPO on 2022-10-05. The company aims at providing effective diagnostic and therapeutic solutions for resistant and metastatic cancers. The Company’s technologies from Oncodesign, are OncoSNIPER for the selection of therapeutic targets using artificial intelligence; Nanocyclix for the design and selection of macrocyclic small molecule kinase inhibitors and Theranostics for the design and selection of radiolabeled biological molecules for systemic radiotherapy. The company focuses on the research and development of therapeutic and diagnostic solutions in the clinical and preclinical areas of medical oncology.
What is the stock price of ONCODESIGN PRECISION MEDICIN today?
The current stock price of ALOPM.PA is 0.475 EUR. The price decreased by -1.45% in the last trading session.
Does ONCODESIGN PRECISION MEDICIN pay dividends?
ALOPM.PA does not pay a dividend.
How is the ChartMill rating for ONCODESIGN PRECISION MEDICIN?
ALOPM.PA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the sector and industry classification for ONCODESIGN PRECISION MEDICIN?
ONCODESIGN PRECISION MEDICIN (ALOPM.PA) operates in the Health Care sector and the Biotechnology industry.
Can you provide the growth outlook for ONCODESIGN PRECISION MEDICIN?
The Revenue of ONCODESIGN PRECISION MEDICIN (ALOPM.PA) is expected to grow by 151.06% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the number of employees for ONCODESIGN PRECISION MEDICIN?
ONCODESIGN PRECISION MEDICIN (ALOPM.PA) currently has 14 employees.